| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 14 |
| 1 | CARBOPLATIN | 9 |
| 2 | PACLITAXEL | 8 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 8 |
| 4 | GEMCITABINE HYDROCHLORIDE | 7 |
| 5 | GEMCITABINE | 6 |
| 6 | PEMBROLIZUMAB | 6 |
| 7 | CYCLOPHOSPHAMIDE | 3 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 3 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NORETHINDRONE AND ETHINYL ESTRADIOL | 2 | 0.0017 |
| 1 | LISOCABTAGENE MARALEUCEL | 1 | 0.0011 |
| 2 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| 3 | TOPOTECAN | 3 | 0.0005 |
| 4 | FINGOLIMOD HYDROCHLORIDE | 1 | 0.0002 |
| 5 | MICAFUNGIN SODIUM | 1 | 0.0002 |
| 6 | GEMCITABINE HYDROCHLORIDE | 7 | 0.0001 |
| 7 | BEVACIZUMAB | 14 | 0.0001 |
| 8 | PACLITAXEL | 8 | 0.0001 |
| 9 | PAZOPANIB HYDROCHLORIDE | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 14 |
| 1 | Microtubule Inhibitor [EPC] | 9 |
| 2 | Platinum-based Drug [EPC] | 9 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 |
| 4 | Alkylating Drug [EPC] | 3 |
| 5 | Estrogen [EPC] | 3 |
| 6 | Interferon beta [EPC] | 3 |
| 7 | Kinase Inhibitor [EPC] | 3 |
| 8 | Topoisomerase Inhibitor [EPC] | 3 |
| 9 | Progestin [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 14 | 0.0001 |
| 2 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 | 0.0001 |
| 4 | Microtubule Inhibitor [EPC] | 9 | 0.0001 |
| 5 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 8 | Platinum-based Drug [EPC] | 9 | 0.0000 |
| 9 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1 | 0.0000 |